Last €62.39 EUR
Change Today 0.00 / 0.00%
Volume 221.4K
MOR On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
As of 3:48 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - morphosys ag (MOR)

Name (Connections)Board RelationshipsTitleKey Developments
Geoffrey Vernon Ph.D., MBA,Ch.Dir,B.Pharama 37 RelationshipsDeputy Chairman of Supervisory Board and Member of Audit Committee 
Daniel Camus 76 RelationshipsMember of Supervisory Board and Chairman of Audit Committee 
Karin Eastham CPA, M.D., Ph.D. 77 RelationshipsMember of Supervisory Board, Member of Audit Committee and Member of Remuneration & Nomination Committee 

Compensation Committee* - morphosys ag (MOR)

Name (Connections)Board RelationshipsTitle
Marc Cluzel M.D., Ph.D. 5 RelationshipsMember of Supervisory Board, Member of Remuneration & Nomination Committee and Member of Scientific & Technology Committee
Karin Eastham CPA, M.D., Ph.D. 77 RelationshipsMember of Supervisory Board, Member of Audit Committee and Member of Remuneration & Nomination Committee
Gerald Möller Ph.D. 66 RelationshipsChairman of Supervisory Board and Chairman of Remuneration & Nomination Committee
MOR Compensation vs. Industry
412.0K
429.1K
Chief Executive Officer
279.5K
336.4K
Chief Financial Officer
Share price activity for MORPHOSYS AG (MOR)
52 Week Price Performance
MOR
Industry Average

Nominating Committee* - morphosys ag (MOR)

Name (Connections)Board RelationshipsTitleKey Developments
Gerald Möller Ph.D. 66 RelationshipsChairman of Supervisory Board and Chairman of Remuneration & Nomination CommitteeMorphosys AG Announces Management Appointments
12/19/13
Karin Eastham CPA, M.D., Ph.D. 77 RelationshipsMember of Supervisory Board, Member of Audit Committee and Member of Remuneration & Nomination CommitteeMorphosys AG Announces Executive Changes
06/1/12
Marc Cluzel M.D., Ph.D. 5 RelationshipsMember of Supervisory Board, Member of Remuneration & Nomination Committee and Member of Scientific & Technology CommitteeMorphosys AG Announces Management Appointments
05/30/12

Supervisory Committee* - morphosys ag (MOR)

Name (Board Relationships)/Title Board Affiliations
Walter Blattler Ph.D. 5 Relationships
Member of Supervisory Board and Chairman of Scientific & Technology Committee
No other board affiliations
Daniel Camus 76 Relationships
Member of Supervisory Board and Chairman of Audit Committee
Marc Cluzel M.D., Ph.D. 5 Relationships
Member of Supervisory Board, Member of Remuneration & Nomination Committee and Member of Scientific & Technology Committee
No other board affiliations
Karin Eastham CPA, M.D., Ph.D. 77 Relationships
Member of Supervisory Board, Member of Audit Committee and Member of Remuneration & Nomination Committee
Gerald Möller Ph.D. 66 Relationships
Chairman of Supervisory Board and Chairman of Remuneration & Nomination Committee
Geoffrey Vernon Ph.D., MBA,Ch.Dir,B.Pharama 37 Relationships
Deputy Chairman of Supervisory Board and Member of Audit Committee
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOR:GR €62.39 EUR 0.00

MOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexion Pharmaceuticals Inc $149.80 USD +0.75
Intrexon Corp $19.27 USD -0.35
XOMA Corp $4.21 USD -0.11
View Industry Companies
 

Industry Analysis

MOR

Industry Average

Valuation MOR Industry Range
Price/Earnings 100.0x
Price/Sales 19.6x
Price/Book 4.6x
Price/Cash Flow 123.2x
TEV/Sales 17.6x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MORPHOSYS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.